Systematic review of 95 studies (30 meta-analysed) in colorectal cancer: guideline-adherent care was associated with a non-significant survival benefit overall (RR 0.90, 95% CI 0.67–1.20), with significant benefit in stage II and III colon cancer subgroups (RR 0.58 each).
Meta-analysisn = 95 studies
Gunasekaran et al. Exploring disparities in adherence to colorectal cancer clinical practice guidelines and associated survival outcomes: a systematic review and meta-analysis